Politico May 10, 2024
Erin Schumaker, Shawn Zeller, Daniel Payne and Ruth Reader

Dr. Shereef Elnahal, the undersecretary for health at the Department of Veterans Affairs, found kindred spirits at a conference in New York today put on by the Horizons Center Public Benefit Corp., which promotes psychedelic drugs.

How so? The VA announced in January that it would fund research into psychedelics like MDMA, also known as ecstasy, and psilocybin as potential treatments for post-traumatic stress disorder and depression. While outside groups have funded studies at the VA, it’s the first time since the 1960s that the agency has put money toward psychedelic research.

The agency has about 13 psychedelic studies underway and is looking to expand, Elnahal said Friday.

For that work, Elnahal received a standing ovation.

“We keep proving the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Mental Health, Provider, VA / DoD
Clinicians' use of health information exchange technologies for medication reconciliation in the U.S. Department of Veterans Affairs: a qualitative analysis.
Government May Be Paying Twice for Veterans’ Health Care in Medicare Advantage Plans
Federal government may be paying twice for care of veterans enrolled in Medicare Advantage plans
What U.S. veterans with ALS deserve to know
Can Healthcare Leaders Learn From the VA’s Virtual Care Dilemma?

Share This Article